RxDoctor Payments Data

Jefferson Futch, DPM

Podiatrist · Ponte Vedra, FLNPI 1629216528

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (38.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Stryker accounts for 97.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $8,012 and has fallen 60.5% since, to $3,164 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,300in general payments, 2019–2025

Across 238 payments — averaging $127.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$29K
  • Smith+Nephew$139
  • Organogenesis Inc.$127
  • Crossroads Extremity Systems, LLC$79
  • Amgen$77
  • Highridge Medical LLC$52
  • plus $401 from 16 others

What the payments were for

  • Consulting fees$11,00036%
  • Travel & lodging$11,71239%
  • Food & beverage$7,58725%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,300 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida

Medicare billing

Part B allowed, 2024
$325,945
Medicare patients
689
Services billed
4,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole63$1,507
Terbinafine Hcl51$902
Pregabalin15$857
Ciclopirox22$855
Gabapentin35$341
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen48$338
Meloxicam33$123
Cephalexin11$107
Triamcinolone Acetonide12$53
Tramadol Hcl13$20

Paid to pharmacies, not to this prescriber.

Other podiatrist in Ponte Vedra

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →